Department of Agricultural, Food & Nutritional Sciences, University of Alberta, Edmonton, Alberta, Canada.
Department of Occupational Therapy, University of Alberta, Edmonton, Alberta, Canada.
JPEN J Parenter Enteral Nutr. 2020 Mar;44(3):407-418. doi: 10.1002/jpen.1681. Epub 2019 Jul 22.
Malnutrition is a common complication in children with chronic diseases. Sarcopenia is one component of malnutrition, characterized by reduced skeletal muscle mass (SMM) and muscle function. The presence of sarcopenia is associated with adverse outcomes in children. Although there is growing research interest in sarcopenia, no review has been done on this novel concept in pediatrics. The purpose of this review was to explore current evidence in sarcopenia with and without obesity and to evaluate the knowledge gaps in the assessment of childhood sarcopenia.
A total of 12 articles retrieved from PubMed or Web of Science databases were included.
Limited studies have elucidated sarcopenia in pediatrics. Challenges in sarcopenia assessment include heterogeneity in definition and absence of standardized body composition methods used to measure SMM and muscle function tests. There is a lack of age-specific and gender-specific normative data for SMM, particularly in young children and infants. None of the studies incorporated muscle function assessment, causing potential bias and misclassification of sarcopenia. The research in childhood sarcopenia is also hampered by low study quality, limited number of outcomes-based research, and lack of longitudinal data.
Consensus needs to be reached in methodological approaches in sarcopenia diagnosis, body composition measurements, and age-appropriate muscle function tests in pediatrics. Careful considerations on growth, neurocognitive status, and factors influencing development in various clinical populations are warranted. Early identification of sarcopenia is crucial to enable targeted treatment and prevention to be carried out across the pediatric clinical populations.
营养不良是慢性疾病儿童的常见并发症。肌少症是营养不良的一个组成部分,其特征是骨骼肌质量(SMM)和肌肉功能下降。肌少症的存在与儿童的不良结局相关。尽管人们对肌少症越来越感兴趣,但在儿科领域尚未对这一新概念进行综述。本综述旨在探讨有或无肥胖的肌少症的现有证据,并评估儿童肌少症评估中的知识空白。
共纳入了从 PubMed 或 Web of Science 数据库中检索到的 12 篇文章。
有限的研究阐明了儿科肌少症。肌少症评估的挑战包括定义的异质性和缺乏用于测量 SMM 和肌肉功能测试的标准化身体成分方法。缺乏特定年龄和性别的 SMM 参考数据,尤其是在幼儿和婴儿中。没有研究纳入肌肉功能评估,这可能导致肌少症的潜在偏倚和分类错误。儿童肌少症的研究也受到研究质量低、基于结局的研究数量有限以及缺乏纵向数据的限制。
需要在肌少症诊断、身体成分测量以及儿科中适合年龄的肌肉功能测试方面达成方法学方法的共识。需要仔细考虑各种临床人群中生长、神经认知状态和影响发育的因素。早期识别肌少症对于在儿科临床人群中进行有针对性的治疗和预防至关重要。